These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6204566)
1. In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes. Grieco MH; Reddy MM; Manvar D; Ahuja KK; Moriarty ML Ann Intern Med; 1984 Aug; 101(2):206-7. PubMed ID: 6204566 [No Abstract] [Full Text] [Related]
2. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms. Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111 [TBL] [Abstract][Full Text] [Related]
3. Immunopotentiation of impaired lymphocyte functions in vitro by isoprinosine in prodromal subjects and AIDS patients. Tsang P; Lew F; O'Brien G; Selikoff IJ; Bekesi JG Int J Immunopharmacol; 1985; 7(4):511-4. PubMed ID: 2412972 [TBL] [Abstract][Full Text] [Related]
4. The mechanism and modulation of immune dysfunction in AIDS associated syndromes. Bekesi JG; Tsang P; Roboz JP Adv Exp Med Biol; 1985; 187():141-50. PubMed ID: 2412416 [No Abstract] [Full Text] [Related]
5. Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS). Tsang PH; Tangnavarad K; Solomon S; Bekesi JG J Clin Immunol; 1984 Nov; 4(6):469-78. PubMed ID: 6210301 [TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions. Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173 [TBL] [Abstract][Full Text] [Related]
8. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)]. Morin A; Griscelli C; Daguillard F Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345 [TBL] [Abstract][Full Text] [Related]
9. Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients. Tsang PH; Zanjani MD; Warner N; Bekesi JG J Clin Lab Immunol; 1986 Aug; 20(4):159-65. PubMed ID: 2428980 [TBL] [Abstract][Full Text] [Related]
10. [A warning against exaggerated optimism about isoprinosine in HIV infection]. Norrby R Lakartidningen; 1990 Aug; 87(32-33):2487-8. PubMed ID: 1697923 [No Abstract] [Full Text] [Related]
11. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol]. Grossmann D; Behrens MI Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884 [TBL] [Abstract][Full Text] [Related]
12. Normalization of immunoregulatory T-helper T-suppressor sublineages and cell-mediated immunity by isoprinosine in vitro in the early stages of AIDS. Tsang P; Bekesi JG Cancer Detect Prev Suppl; 1987; 1():611-8. PubMed ID: 2446761 [TBL] [Abstract][Full Text] [Related]
13. Modulation of human T lymphocyte functions by isoprinosine. Rey A; Cupissol D; Thierry C; Esteve C; Serrou B Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707 [TBL] [Abstract][Full Text] [Related]
14. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice. Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762 [TBL] [Abstract][Full Text] [Related]
15. AIDS therapy. Stephens EJ N Z Med J; 1986 Feb; 99(795):72-3. PubMed ID: 2418393 [No Abstract] [Full Text] [Related]
16. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS. Bekesi JG; Tsang PH; Wallace JI; Roboz JP J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254 [TBL] [Abstract][Full Text] [Related]
17. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin. Sundar SK; Menezes J Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730 [TBL] [Abstract][Full Text] [Related]
18. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance. Glasky AJ; Gordon JF Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760 [TBL] [Abstract][Full Text] [Related]
19. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice. Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109 [TBL] [Abstract][Full Text] [Related]
20. Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS). Tsang KY; Donnelly RP; Galbraith GM; Fudenberg HH Int J Immunopharmacol; 1986; 8(4):437-41. PubMed ID: 2427461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]